A study published in Scientific Reports found that cannabidiol (CBD) disrupts lipid metabolism and induces apoptosis in ...

The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...

Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

The medium was replaced with serum-free medium (Gibco, Cat. No. 31603-029) to prevent cell proliferation during the migration phase. The cells were then cultured in a 37°C incubator with 5% CO 2.

Body Dimensions 163.8 x 75 x 8.3 mm (6.45 x 2.95 x 0.33 in) ...

A study published by the Journal of Traditional and Complementary Medicine and e-published by the U.S. National Library of Medicine highlights cannabidiol’s (CBD) potential as a therapeutic option for ...

近日，宇树科技推出G1人形机器人首个应用方案——Unitree G1-Comp，据悉这是一款为赛事打造的“足球巨星”。 据宇树官网资料，G1-Comp身高130cm，体重35kg，续航约2小时，支持快充快换，能在足球场地上做出全向行走、转身、奔跑、转圈等动作，拥有稳定的步态和 ...

A lit­tle-known Chi­nese biotech start­up has zipped ahead of US com­pa­nies in one of the gene edit­ing field’s most com­pet­i­tive races.

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human immunoglobulin G1 (IgG1) monoclonal antibody ... In June 2024, the company ...

But it wasn’t until 2011 that Bran­g­-wynne, Hyman and veteran cell biologist Tim Mitchison of Harvard Medical School clarified what nucleoli actually are: phase-separated liquidlike droplets.